| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9M | — | -11.7% |
| Cost of Revenue | $1.3M | — | -1.7% |
| Gross Profit | $1.6M | — | -18.6% |
| R&D Expense | $1.4M | — | +18.6% |
| SG&A Expense | $1.9M | — | -7.7% |
| Operating Income | -$1.7M | — | -199.8% |
| Pre-tax Income | -$1.4M | — | -180.5% |
| Net Income | -$1.4M | — | -180.5% |
| EPS (Basic) | -$0.03 | — | -150.0% |
| EPS (Diluted) | -$0.03 | — | -150.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.6M | -45.8% | +214.0% |
| Accounts Receivable | $2.7M | +110.5% | +12.4% |
| Inventory | $1.7M | -25.2% | -13.7% |
| Current Assets | $8.1M | -21.1% | +41.2% |
| Total Assets | $8.6M | -20.5% | +32.1% |
| Current Liabilities | $1.3M | -45.4% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.1M | — | -1597.6% |
| Capital Expenditures | $41K | — | +66.9% |
| Investing Cash Flow | -$41K | — | -66.9% |
| Financing Cash Flow | $148K | — | +129.0% |
| Free Cash Flow | -$3.2M | — | -1819.0% |
| -19.9% |
| Total Liabilities | $2.2M | -41.4% | -38.9% |
| Stockholders' Equity | $6.4M | -9.5% | +118.1% |